Healthscope float: first day success sign of more IPOs to come

“We like management, we like the business, we understand that private equity operators need to gut out of there, but at the end of the day, it’s just an expensive for here and now, even though it’s a quality investment,” Mr Boubouras added. At an issue price of $2. 10, Healthscope shares were trading at a price-earnings ratio of nearly 22 - well above the market average in the mid-teens - and the company’s dividend yield is just 3 per cent.

Read more here: ABC

    

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>